GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Allen Institute Launches Next Phase of Mapping the Human Brain With $173 Million
2022-09-23
BridgeBio and Sentynl Therapeutics’ Nulibry Gets Greenlighted In Europe
2022-09-21
Aurinia Wins Approval For Lupus Nephritis Therapy In Europe
2022-09-20
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
China’s Biocytogen And FineImmune Bring TCR-Mimic Antibodies And Cell Therapy Together
2022-09-16
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
QOL Medical’s Sucraid Single-Use Containers Approved For Patients With Sucrase Deficiency
2022-09-07
AstraZeneca’s Imfinzi Combination Becomes First Approved Immunotherapy Regimen For Biliary Tract Cancer
2022-09-06
1 … 7 8 9 10 11 … 25
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top